U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Dr. Reed Tuckson: Vaccines and the Role ofMonoclonal Antibody Treatment

VIDEOS ON MONOCLONAL ANTIBODIES (mAbs)
 

Video Icon FEATURED VIDEO

Vaccines and the Role of Monoclonal Antibody Treatment
Dr. Reed Tuckson, founding member of the Black Coalition Against COVID, discusses how clinicians can counsel their patients about vaccination and mAb treatment. Note: The mAb needs to be administered within 7 days of when symptoms first start.


LEARN MORE ABOUT mAbs

Watch the videos below for tips on counseling your patients with COVID-19 about mAb treatments.

Lessons Learned: Monoclonal Antibody Treatment for COVID-19

LESSONS LEARNED: MONOCLONAL ANTIBODY TREATMENT FOR COVID-19

Clinicians and healthcare professionals discuss what they have learned throughout the COVID-19 pandemic. They also share advice for healthcare professionals as they continue to treat high-risk patients.

Improved Patient Outcomes: Monoclonal Antibody Treatment for COVID-19

IMPROVED PATIENT OUTCOMES: MONOCLONAL ANTIBODY TREATMENT FOR COVID-19

Clinicians and healthcare professionals discuss the challenges they faced at the onset of the COVID-19 pandemic. They also describe how mAb treatment helped improve outcomes for their high-risk patients.

Treating High-Risk COVID-19 Patients with Monoclonal Antibodies

TREATING HIGH-RISK COVID-19 PATIENTS WITH MONOCLONAL ANTIBODIES

In the video above, you’ll learn more about mAbs, how they can be used to treat your high-risk patients with COVID-19, and how you can find treatment centers near you. Note: The mAb needs to be administered within 7 days of when symptoms first start.


HEALTHCARE PROFESSIONALS' EXPERIENCES

In these short videos, healthcare professionals in different settings discuss how they have increased patient access to mAb treatment.

Community Outreach for Monoclonal Antibody Treatment

COMMUNITY OUTREACH FOR MONOCLONAL ANTIBODY TREATMENT

Dr. Theresa Cullen, Public Health Director for Pima County, Arizona, discusses how she worked to make mAb treatment for COVID-19 available to high-risk populations in her community.

Dr. Jennifer Tuteur: The Importance of Equitable Access to Monoclonal Antibodies forCOVID-19

DR. JENNIFER TUTEUR: THE IMPORTANCE OF EQUITABLE ACCESS TO MONOCLONAL ANTIBODIES FOR COVID-19

Dr. Jennifer Tuteur, Deputy Chief Medical Officer for San Diego County, discusses the critical role mAb treatment plays in treating high-risk patients with COVID-19 and strategies for reaching vulnerable populations in her community.

Dr. Mary Dittrich: Administering Monoclonal Antibodies to High-Risk COVID-19 Patients

DR. MARY DITTRICH: ADMINISTERING MONOCLONAL ANTIBODIES TO HIGH-RISK COVID-19 PATIENTS

Dr. Mary Dittrich, Chief Medical Officer for U.S. Renal Care, discusses how she set up infusion centers in dialysis centers to ensure high-risk patients received timely access to mAb treatment.

Grand View and TriValley Primary Care - Community Collaboration to Administer Monoclonal Antibodies

GRAND VIEW AND TRIVALLEY PRIMARY CARE: COMMUNITY COLLABORATION TO ADMINISTER MONOCLONAL ANTIBODIES

Pharmacists from Grand View Health in Pennsylvania, and primary care physicians from Grand View Medical and TriValley Primary Care, discuss how they brokered powerful partnerships in their community to ensure high-risk patients with COVID-19 received mAb treatment.

Drs. Karen Murphy & Keith Boell: Monoclonal Antibody Treatment in a Health System Setting

DRS. KAREN MURPHY & KEITH BOELL: MONOCLONAL ANTIBODY TREATMENT IN A HEALTH SYSTEM SETTING

Drs. Karen Murphy and Keith Boell discuss their people-first approach to community health, and the proactive measures they took to identify and counsel high-risk patients with COVID-19 about mAbs as a treatment option.

Equitable Access to Monoclonal Antibody Treatmentfor COVID-19

EQUITABLE ACCESS TO MONOCLONAL ANTIBODY TREATMENT

Physicians at healthcare facilities nationwide discuss their efforts to ensure equitable access to mAb treatment for high-risk patients with COVID-19.

Providers interviewed include: Dr. Reid Tuckson, Dr. Keith Boell, Dr. Karen Murphy, Dr. Gary Wiltz, Dr. Terese Hammond, and Dr. Jennifer Tuteum.

Dr. Natalie McGann: Monoclonal Antibody Treatment in a Primary Practice Setting

DR. NATALIE MCGANN: MONOCLONAL ANTIBODY TREATMENT IN A PRIMARY PRACTICE SETTING

Dr. Natalie McGann of TriValley Primary Care discusses how the organization overcame obstacles to administer mAb treatments to high-risk patients with COVID-19 in a primary practice setting.

Dr. Gary Wiltz - Monoclonal Antibody Treatment Testimonial

DR. GARY M. WILTZ, CEO/CLINICAL CHO, TECHE ACTION CLINIC

Dr. Gary M. Wiltz speaks about the challenges of treating patients with COVID-19 in rural Southeast Louisiana. Together with local church leaders and TV and radio stations, he is spreading the word about the benefits of mAb treatment for high-risk patients with COVID-19.


PATIENT EXPERIENCES

Dr. Quinn and Colin Bander Testimonial

COLIN QUINN SPEAKS TO DR. JEFFREY BANDER

Stand-up comedian Colin Quinn (Saturday Night Live, Tough Crowd) speaks to Dr. Jeffrey Bander from Mount Sinai Hospital about how mAbs helped Colin recover from COVID-19.

Amy Hill - Monoclonal Antibodies Testimonial

AMY HILL: MY EXPERIENCE WITH MONOCLONAL ANTIBODY TREATMENT

Filmmaker Amy Hill describes her experience with COVID-19 and how mAb treatment helped speed up her recovery.


PAST EVENTS

The Future of Vaccines, Variants, and Treatment: The Vital Role of COVID-19 Monoclonal Antibodies

THE FUTURE OF VACCINES, VARIANTS, AND TREATMENT: THE VITAL ROLE OF COVID-19 MONOCLONAL ANTIBODIES

Watch Dr. John Redd of the U.S. Department of Health and Human Services (HHS) and Dr. Lauri Hicks of the Centers for Disease Control and Prevention discuss this topic.

Equitable Access to Monoclonal Antibody Treatment: Examples From Two States

EQUITABLE ACCESS TO MONOCLONAL ANTIBODY TREATMENT: EXAMPLES FROM TWO STATES

Watch Dr. Joneigh Khaldun (Chief Medical Executive for the State of Michigan and Chief Deputy Director for Health in the Michigan Department of Health and Human Services) and Dr. Howard Haft (Executive Director of the Maryland Primary Care Program) discuss their insights on equitable access to mAb treatment for high-risk patients with COVID-19 in their respective states. Moderated by Ms. Cicely Waters (HHS/Office of the Assistant Secretary for Preparedness and Response [ASPR]).

Dr. Michael Anderson on effectiveness of monoclonal antibodies | COVID-19 Update for June 24, 2021

WHAT PHYSICIANS NEED TO KNOW ABOUT MONOCLONAL ANTIBODIES

Watch a discussion with Dr. Michael Anderson, Senior Advisor at HHS ASPR, on what physicians need to know about mAb treatments and their effectiveness in helping certain patients avoid going to the hospital for COVID-19.

Discussion on Monoclonal Antibody Treatment with Dr. Vin Gupta and Dr. Robert Califf

DR. VIN GUPTA AND DR. ROBERT CALIFF: THE IMPORTANCE AND SAFETY OF MONOCLONAL ANTIBODIES

This Facebook Live event features Dr. Vin Gupta and former U.S. Food and Drug Administration Commissioner Dr. Robert Califf.

NIH “A” Rating for mAbs

MONOCLONAL ANTIBODIES: TREATMENT GUIDELINES AS OF APRIL 2021

Watch Dr. H. Clifford Lane (National Institutes of Health [NIH]) and Dr. Raj Gandhi (Harvard University) discuss the updated recommendations on the use of mAbs released by the NIH COVID-19 Treatment Guidelines Panel in April 2021. Moderated by Ms. Cicely Waters (HHS/ASPR).


ADMINISTERING mAbs IN YOUR FACILITY

These videos, produced by Mount Sinai Hospital in New York, can help you set up mAb infusions in your facility, learn more about mAb treatment, and increase awareness about its benefits.*

Speakers: Jenny Waltzer, Mount Sinai Director of Oncology and Therapeutic Infusion Services; Lisette Kimbere, Oncology Care Nurse Practitioner; Marisa Marvin, Nurse; and Victoria Adams-Sommer, Infectious Diseases Clinical Pharmacist.

Monoclonal Antibody Treatment: Patient Flow

MONOCLONAL ANTIBODY TREATMENT: PATIENT FLOW

The first in the series is a video that describes the operations and set up of mAb infusion services and addresses optimizing efficiency and patient flow.

Monoclonal Antibody Treatment: Accountability and Safety

MONOCLONAL ANTIBODY TREATMENT: ACCOUNTABILITY AND SAFETY

The second video in the series addresses accountability and safety.

Monoclonal Antibody Treatment: Education Training

MONOCLONAL ANTIBODY TREATMENT: EDUCATION TRAINING

The third video in the series addresses how to manage education and training.

 

*Reference herein to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States Government. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government, and shall not be used for advertising or product endorsement purposes.